Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW842470 12-week randomized trial in COPD pulmonary hyperinflation
2004-000789-11Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing GW842470 4 mg twice daily with Placebo (2 arms). Primary endpoint: Change from baseline in residual volume (RV) measured by plethysmography at Week 12. Started Oct 2004; status: completed.
02
Drugs
GW842470X
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2004-000789-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000789-11.